| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |